Omnicell, Inc.

Omnicell, Inc.

OMCL · Nasdaq

Omnicell, Inc. (OMCL) is a Medical healthcare information services company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Omnicell, Inc. in 2026. The next earnings report is expected on November 4, 2026.

Earnings calendar

Next earnings date

04 Nov 2026

In 77 days

EPS estimate

0.47

Revenue estimate

312.5M

Past earnings

30 Jul 2026
EPS actual
0.94 (+101.1%)
estimate 0.47
Revenue actual
312.2M (+0.6%)
estimate 310.2M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
28 Apr 2026
EPS actual
0.55 (+66.0%)
estimate 0.33
Revenue actual
309.9M (+1.9%)
estimate 304.0M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
05 Feb 2026
EPS actual
0.40 (-19.4%)
estimate 0.50
Revenue actual
314.0M (+0.2%)
estimate 313.4M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
30 Oct 2025
EPS actual
0.51 (+40.7%)
estimate 0.36
Revenue actual
310.6M (+5.1%)
estimate 295.6M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Beat Miss usd

Latest earnings analysis

Omnicell, Inc. beat consensus estimates in its latest earnings report, with EPS of $0.94 coming in 101.1% above expectations and revenue of $312.21 million exceeding estimates by 0.6%. Both EPS and revenue also came in ahead of expectations in the previous report.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.

Sector
Healthcare
Industry
Medical healthcare information services
Country
United States
Exchange
Nasdaq
CEO
Randall A. Lipps
Employees
3,620
IPO date
09 Aug 2001
ISIN
US68213N1090
Website
omnicell.com

Frequently asked questions

When does Omnicell, Inc. (OMCL) next report earnings?

Omnicell, Inc. (OMCL) is scheduled to report earnings on November 4, 2026.

What was Omnicell, Inc.'s most recent earnings date?

Omnicell, Inc. (OMCL) last reported earnings on July 30, 2026.

Where is Omnicell, Inc. stock listed?

Omnicell, Inc. (OMCL) is listed on Nasdaq.